IRIS
GITTO, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.268
EU - Europa 13.600
AS - Asia 6.674
SA - Sud America 2.201
Continente sconosciuto - Info sul continente non disponibili 372
AF - Africa 203
OC - Oceania 12
Totale 45.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.894
RU - Federazione Russa 7.084
SG - Singapore 2.824
BR - Brasile 1.887
CN - Cina 1.666
IE - Irlanda 1.570
SE - Svezia 1.335
IT - Italia 823
VN - Vietnam 677
UA - Ucraina 615
HK - Hong Kong 606
DE - Germania 580
GB - Regno Unito 407
FR - Francia 382
FI - Finlandia 313
IN - India 301
CA - Canada 169
AR - Argentina 112
BD - Bangladesh 96
PL - Polonia 78
MX - Messico 73
IQ - Iraq 67
JP - Giappone 64
CZ - Repubblica Ceca 62
NL - Olanda 62
BE - Belgio 58
AT - Austria 53
ZA - Sudafrica 53
TR - Turchia 52
EC - Ecuador 51
MA - Marocco 47
ES - Italia 39
UZ - Uzbekistan 38
CI - Costa d'Avorio 33
CO - Colombia 32
CL - Cile 29
ID - Indonesia 29
VE - Venezuela 26
PK - Pakistan 25
JM - Giamaica 23
PY - Paraguay 21
SA - Arabia Saudita 20
CR - Costa Rica 19
AE - Emirati Arabi Uniti 17
HN - Honduras 17
UY - Uruguay 17
JO - Giordania 16
EG - Egitto 15
GR - Grecia 15
IR - Iran 15
AZ - Azerbaigian 14
IL - Israele 14
PE - Perù 14
PH - Filippine 14
TT - Trinidad e Tobago 14
LT - Lituania 13
LV - Lettonia 13
MY - Malesia 13
OM - Oman 12
BO - Bolivia 11
NO - Norvegia 11
AL - Albania 10
DO - Repubblica Dominicana 10
KE - Kenya 10
NP - Nepal 10
RO - Romania 10
KZ - Kazakistan 9
LB - Libano 9
NI - Nicaragua 9
DZ - Algeria 8
EE - Estonia 8
GT - Guatemala 8
KR - Corea 8
PA - Panama 8
GP - Guadalupe 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
PS - Palestinian Territory 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
AM - Armenia 6
CH - Svizzera 6
SC - Seychelles 6
AU - Australia 5
CW - ???statistics.table.value.countryCode.CW??? 5
HU - Ungheria 5
LK - Sri Lanka 5
MD - Moldavia 5
PR - Porto Rico 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
DK - Danimarca 4
ET - Etiopia 4
GE - Georgia 4
IS - Islanda 4
LU - Lussemburgo 4
RS - Serbia 4
SV - El Salvador 4
Totale 44.905
Salva come PNG Salva come JPEG
Città #
Dallas 10.088
Moscow 2.023
Ashburn 1.829
Dublin 1.567
Singapore 1.557
Chandler 1.190
Jacksonville 1.145
Nyköping 862
San Jose 767
Beijing 620
Hong Kong 601
Council Bluffs 503
Dong Ket 358
Los Angeles 319
The Dalles 258
Princeton 257
Dearborn 244
Lauterbourg 228
Cambridge 215
Medford 211
Des Moines 191
Messina 182
Ann Arbor 158
Boardman 152
Hyderabad 125
São Paulo 124
Buffalo 122
New York 120
Munich 109
Ho Chi Minh City 107
Woodbridge 89
Lancaster 87
Hanoi 81
Santa Clara 75
Columbus 73
Guangzhou 72
Wilmington 71
Tianjin 68
Brooklyn 67
Pune 64
Orem 63
Phoenix 59
Milan 58
Warsaw 57
Redondo Beach 55
Montreal 54
Brussels 53
Frankfurt am Main 53
San Mateo 53
Seattle 52
Turku 52
Belo Horizonte 50
Chicago 50
Jinan 50
Rome 50
Rio de Janeiro 49
Tokyo 49
Atlanta 48
Houston 45
Brno 43
Vienna 42
Catania 41
Denver 41
Shenyang 41
Tashkent 38
London 37
Johannesburg 36
Brasília 34
Abidjan 33
Amsterdam 33
Nanjing 31
Baghdad 30
Washington 30
Shanghai 29
Stockholm 29
Chennai 28
Haikou 28
Helsinki 28
Toronto 28
Curitiba 27
Turin 27
Manchester 26
Nuremberg 26
Porto Alegre 24
San Francisco 24
North Bergen 23
Guayaquil 22
Hangzhou 21
Poplar 21
Taizhou 21
Zhengzhou 21
Boston 20
Dhaka 19
Düsseldorf 19
Fuzhou 19
Lappeenranta 19
Naples 19
Ningbo 19
Newark 18
Ottawa 18
Totale 29.112
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.747
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.729
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 314
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 282
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 278
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 269
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 266
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives 236
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 236
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 227
4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one 226
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 223
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 221
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 213
Anticonvulsant agent: enhancement of physicochemical properties 212
AMPA receptor antagonists: Synthesis and pharmacological evaluation 211
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 210
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 209
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]-benzodiazepin-8(7H)-one 205
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 205
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 201
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 200
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 200
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 200
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 198
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 198
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 197
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 196
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 196
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 194
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 194
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 193
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 193
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 190
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 189
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 188
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 188
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 186
Design and synthesis of acetylcholinesterase inhibitors 185
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 184
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 180
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 180
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 178
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 178
2,3-Benzodiazepines as potential AMPA receptors antagonists 177
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 177
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 174
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 174
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 174
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 173
Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae 172
Antiretroviral strategy using multi-target agents 172
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 170
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 170
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 169
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 168
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 168
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 168
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 167
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 167
Binding modes of noncompetitive AMPA antagonists: a computational approach 166
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 166
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 166
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 166
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 166
Leveraging the 3-Chloro-4-fluorophenyl Motif to Identify Inhibitors of Tyrosinase from Agaricus bisporus 165
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 163
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 162
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 162
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 160
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 159
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 159
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 159
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 158
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 157
Annelated 1,5-benzothiazepines 157
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 156
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 156
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 156
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 156
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 155
ELECTRONIC-PROPERTIES OF THIENODIAZEPINE AND BENZODIAZEPINE DERIVATIVES 154
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 153
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 152
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 151
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation 150
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 149
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 149
Exploring the MUC1/CIN85 interaction to investigate a small library of peptide inhibitors as potential anti-metastatic agents 149
Searching for alpha-syn inhibitors to fight Parkinson’s disease 148
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 147
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 146
Synthesis, Structure-Activity Relationship Studies, and X-ray Crystallographic Analysis of Arylsulfonamides as Potent Carbonic Anhydrase Inhibitors. 146
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 145
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 145
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 145
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 144
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 143
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 143
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 143
Totale 27.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.259 0 0 0 0 64 30 135 59 38 79 320 534
2022/20234.717 368 418 208 423 348 464 94 242 1.912 16 168 56
2023/20241.343 94 189 81 253 107 235 20 64 5 155 23 117
2024/20255.302 83 103 124 311 248 150 149 1.203 1.297 318 493 823
2025/202624.731 733 3.519 7.511 1.313 1.281 3.676 1.817 1.959 1.875 599 244 204
2026/20272.551 230 633 739 887 62 0 0 0 0 0 0 0
Totale 45.330